Related Experiment Video
Updated: Nov 28, 2025
05:59
Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
2.8K
Recognizing and Treating Excessive Daytime Sleepiness in Patients With Narcolepsy
Thomas Roth1, John W Winkelman2
1Henry Ford Hospital Sleep Center and Department of Psychiatry, Wayne State University School of Medicine, Detroit, and Department of Psychiatry, University of Michigan College of Medicine, Ann Arbor.
The Journal of Clinical Psychiatry
|November 25, 2020
Summary
Narcolepsy and other sleep disorders cause excessive daytime sleepiness (EDS). Early screening and consistent patient follow-up can shorten the lengthy diagnosis time for EDS, enabling prompt treatment.
Area of Science:
- Neurology
- Sleep Medicine
Background:
- Excessive daytime sleepiness (EDS) is a common symptom of sleep disorders, notably narcolepsy.
- Diagnosis of narcolepsy is frequently delayed, leading to prolonged patient suffering and delayed treatment.
- Current diagnostic pathways for EDS and narcolepsy can be improved.
Purpose of the Study:
- To highlight the importance of screening tools in recognizing EDS.
- To emphasize the need for consistent clinical follow-up for patients with EDS.
- To discuss current and needed therapeutic strategies for narcolepsy and EDS.
Main Methods:
- Review of diagnostic challenges and screening tools for EDS.
- Discussion of pharmacologic and nonpharmacologic treatment options for narcolepsy.
- Exploration of the role of hypocretin deficiency in narcolepsy pathogenesis.
Main Results:
- Screening tools like the Epworth Sleepiness Scale can aid in early EDS recognition.
- Continued patient assessment and follow-up are crucial for timely diagnosis.
- Existing treatments effectively reduce EDS for some, but complete elimination is not yet achieved.
- Nonpharmacologic strategies and ongoing monitoring are vital components of management.
Conclusions:
- Improved clinical recognition and timely diagnosis of EDS are achievable through systematic approaches.
- While current treatments offer benefits, further research into hypocretin-based therapies is warranted for narcolepsy.
- Comprehensive management of narcolepsy and EDS requires a combination of pharmacologic, nonpharmacologic, and monitoring strategies.
Related Concept Videos
01:07Narcolepsy
321
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
321
01:24Sleep-Wake Cycles
2.4K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.4K
01:19Management of Insomnia
404
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
404
01:21Sleep Apnea
332
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
The condition is more prevalent among...
332
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
349
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
349
01:17Sleepwalking and Sleep Talking
521
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
521